{
    "2021-07-08": [
        [
            {
                "time": "2023-10-01",
                "original_text": "Biogen Stock Just Popped For An Odd Reason â€” Here's Why",
                "features": {
                    "keywords": [
                        "Biogen",
                        "Stock",
                        "Popped",
                        "Odd Reason"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2023-10-01",
                "original_text": "Biogen Stock Pops Despite New FDA Limits On Alzheimer's Drug Use",
                "features": {
                    "keywords": [
                        "Biogen",
                        "Stock",
                        "Pops",
                        "FDA",
                        "Limits",
                        "Alzheimer's Drug"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2023-10-01",
                "original_text": "SNY vs. LLY: Which Stock Is the Better Value Option?",
                "features": {
                    "keywords": [
                        "SNY",
                        "LLY",
                        "Stock",
                        "Value Option"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2023-10-01",
                "original_text": "Eli Lilly, Verge Genomics Ink $720M Pact For Amyotrophic Lateral Sclerosis Therapies",
                "features": {
                    "keywords": [
                        "Eli Lilly",
                        "Verge Genomics",
                        "Pact",
                        "Amyotrophic Lateral Sclerosis",
                        "Therapies"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}